Product Information

CANDESARTAN-HYDROCHLOROTHIAZIDE 32-25 MG TAB is a generic product labeled by Solco Healthcare US LLC, priced at $1.0348 per EA under NDC 43547046109. Its NADAC has been published 177 times since Jul 5, 2023.

FDA first approved this application on Apr 11, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

CANDESARTAN-HYDROCHLOROTHIAZIDE 32-25 MG TAB

candesartan cilexetil and hydrochlorothiazide
$1.0348per EA

Strength

32; 25 mg/1; mg/1

NDC

43547046109

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA207455

FDA Approved

4/11/2018

TE Code

AB

On Market Since

11/20/2017

Pharmacological Classes

Angiotensin 2 Receptor Antagonists
Angiotensin 2 Receptor Blocker
Increased Diuresis
Thiazide Diuretic
Thiazides

Price Statistics

The NADAC for CANDESARTAN-HYDROCHLOROTHIAZIDE 32-25 MG TAB has been published 177 times since Jul 5, 2023, and over the history we have for it it has declined 21.2%. The table below summarizes its recorded NADAC range and movement.

Current price$1.0348 per EA
All-time high$1.7766 (Jan 10, 2024)
All-time low$0.9491 (Oct 22, 2025)
52-week high$1.2433
52-week low$0.9917
Median price$1.2086
Average price$1.2654
Largest weekly change+31.9% (Dec 20, 2023)
Weeks tracked177
Tracking sinceJul 5, 2023

Price History

1W

-7.5%

1M

-4.0%

3M

+1.3%

6M

-16.8%

1Y

+4.3%

3Y

-23.2%

5Y

N/A

All

-21.2%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 1% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of CANDESARTAN-HYDROCHLOROTHIAZIDE 32-25 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for CANDESARTAN-HYDROCHLOROTHIAZIDE 32-25 MG TAB, manufactured by Solco Healthcare US LLC, is $1.0348 per EA (NDC 43547046109), effective Nov 18, 2026.

How has the price of CANDESARTAN-HYDROCHLOROTHIAZIDE 32-25 MG TAB changed over time?

Over the history we have for it, the NADAC for CANDESARTAN-HYDROCHLOROTHIAZIDE 32-25 MG TAB has declined 21.2%. It has been tracked across 177 weekly CMS publications since Jul 5, 2023.

What are the highest and lowest recorded NADAC prices for CANDESARTAN-HYDROCHLOROTHIAZIDE 32-25 MG TAB?

Since Jul 5, 2023, the NADAC for CANDESARTAN-HYDROCHLOROTHIAZIDE 32-25 MG TAB has ranged from a low of $0.9491 (Oct 22, 2025) to a high of $1.7766 (Jan 10, 2024), with a median of $1.2086 per EA.

Are there cheaper alternatives to CANDESARTAN-HYDROCHLOROTHIAZIDE 32-25 MG TAB?

Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CANDESARTAN-HYDROCHLOROTHIAZIDE 32-25 MG TAB, is $1.0214 per EA — about 1% below CANDESARTAN-HYDROCHLOROTHIAZIDE 32-25 MG TAB.

Who manufactures CANDESARTAN-HYDROCHLOROTHIAZIDE 32-25 MG TAB?

CANDESARTAN-HYDROCHLOROTHIAZIDE 32-25 MG TAB (NDC 43547046109) is labeled by Solco Healthcare US LLC, and CMS classifies it as a generic product.